🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

135,26 USD

Máx. histórico

158,62

80 días

Caída desde máximo

-14,73%

Rango 52 semanas

76,70 – 160,81

Variación hoy

-5,66%

Cierre anterior

143,37

Rango de hoy

134,39 – 143,30

Volumen hoy

582.605

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,33%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
131,32 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 9 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/04/2022 19,67 20,21 19,00 19,18 -2,94% 6,11% 789.100
20/04/2022 19,51 20,05 18,90 19,76 +2,12% 5,91% 547.000
19/04/2022 19,19 20,00 18,67 19,35 +0,83% 6,93% 948.400
18/04/2022 20,48 20,52 18,93 19,19 -3,81% 7,79% 1.201.500
14/04/2022 20,09 21,37 19,16 19,95 -21,83% 11,00% 4.877.100
13/04/2022 23,58 25,66 23,58 25,52 +8,32% 8,82% 1.153.900
12/04/2022 24,37 25,24 23,22 23,56 -2,08% 8,29% 576.800
11/04/2022 24,93 25,76 23,82 24,06 -4,41% 7,78% 622.500
08/04/2022 25,35 25,63 24,84 25,17 -0,98% 3,12% 606.500
07/04/2022 24,37 25,76 24,27 25,42 +3,76% 6,11% 441.900
06/04/2022 23,86 24,61 23,45 24,50 +1,07% 4,86% 544.800
05/04/2022 25,27 25,38 24,16 24,24 -2,69% 4,83% 1.219.400
04/04/2022 23,88 25,31 23,88 24,91 +3,02% 5,99% 583.500
01/04/2022 23,84 24,68 23,70 24,18 +2,11% 4,13% 840.600
31/03/2022 23,92 24,28 23,47 23,68 -1,00% 3,39% 315.800
30/03/2022 24,93 25,41 23,87 23,92 -4,70% 6,18% 461.200
29/03/2022 24,94 26,00 24,75 25,10 +1,13% 5,01% 776.400
28/03/2022 25,01 25,18 24,08 24,82 -0,56% 4,40% 472.500
25/03/2022 25,43 25,97 24,73 24,96 -0,83% 4,88% 465.900
24/03/2022 25,00 25,67 23,15 25,17 -3,60% 10,08% 1.241.500
23/03/2022 26,55 26,61 25,50 26,11 -1,62% 4,18% 680.500
22/03/2022 25,65 26,67 24,84 26,54 +5,07% 7,13% 514.100
21/03/2022 27,29 27,31 25,19 25,26 -7,06% 7,77% 585.300
18/03/2022 26,74 27,41 25,82 27,18 -0,29% 5,95% 1.285.600
17/03/2022 26,27 27,30 26,00 27,26 +2,91% 4,95% 458.400
16/03/2022 26,34 26,63 25,31 26,49 +2,59% 5,01% 413.200
15/03/2022 24,97 26,00 24,92 25,82 +3,74% 4,31% 289.900
14/03/2022 25,68 26,10 24,49 24,89 -2,43% 6,29% 707.100
11/03/2022 26,54 26,66 25,22 25,51 -2,78% 5,43% 361.000
10/03/2022 24,89 26,38 24,01 26,24 +3,27% 9,52% 508.600